Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;29(8):2173-2180.
doi: 10.1111/ene.15370. Epub 2022 May 27.

Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels

Bérenger Largeau  1   2   3 , Arnaud Karam  1   2   4 , Camille Potey  1   2   5 , Anne-Sylvie Caous  1   2   3 , Céline Tard  1   2   4 , Louise Carton  1   2   3 , Grégory Kuchcinski  1   2   6 , Sophie Gautier  1   2   5 , Sylvie Deheul  1   2   3   7 , Régis Bordet  1   2   3   5
Affiliations

Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels

Bérenger Largeau et al. Eur J Neurol. 2022 Aug.

Abstract

Background and purpose: Although several case series have described nitrous-oxide-associated neurological disorders, a comprehensive assessment of exposure characteristics (e.g., time to onset, level of exposure) in substance abusers has not been performed. The aim of this study was to describe the onset patterns of recreational use of nitrous-oxide-induced neurological disorders.

Methods: All cases of neurological disorders related to nitrous oxide recreational use reported to the Hauts-de-France addictovigilance center between January 2019 and August 2020 were selected. Only cases requiring hospitalization with informative data to perform the nitrous oxide causality assessment were included.

Results: A total of 20 cases from five hospitals were included. The male-to-female ratio was 6:1 and the median age was 19 years (range 16-34). The neurological presentation (myeloneuropathy 64%, 7/11; sensorimotor neuropathy 36%, 4/11) included for all patients gait disorders due to proprioceptive ataxia and limb hypoesthesia. The median dose used per occasion was 100 cartridges (range 5-960; n = 19). The median time from the start of nitrous oxide use to the onset of neurological symptoms was 6 months (range 0.7-54; n = 16). The cumulative dose was significantly higher in patients with damage to all four limbs than in patients with lower limb symptoms only (p = 0.042).

Conclusions: A low intermittent exposure may be sufficient to cause neurological damage in some subjects, suggesting that, at the population level, there is no safe exposure to nitrous oxide in recreational settings. The severity of neurological impairment could increase once used at high doses and for prolonged durations of nitrous oxide.

Keywords: myelopathy; neuropathy; nitrous oxide; toxicology; vitamin B12.

PubMed Disclaimer

References

REFERENCES

    1. Garakani A, Jaffe RJ, Savla D, et al. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature. Am J Addict. 2016;25(5):358-369.
    1. Zheng D, Ba F, Bi G, Guo Y, Gao Y, Li W. The sharp rise of neurological disorders associated with recreational nitrous oxide use in China: a single-center experience and a brief review of Chinese literature. J Neurol. 2020;267(2):422-429.
    1. Micallef J, Mallaret M, Lapeyre-Mestre M, et al. Warning on increased serious health complications related to non-medical use of nitrous oxide. Therapie. 2021;76(5):478-479.
    1. Jouanjus E, Gibaja V, Kahn J-P, Haramburu F, Daveluy A. Signal identification in addictovigilance: the functioning of the French system. Therapie. 2015;70(2):113-131.
    1. Bethmont A, Harper CE, Chan BS, Dawson AH, McAnulty J. Increasing illicit use of nitrous oxide in presentations to NSW emergency departments. Med J Aust. 2019;211(9):429-429.e1.